Clinical Trial Update: Phlogenzym® in Patients With Acute Thrombophlebitis - Efficacy and Tolerance [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy and tolerability of Phlogenzym in patients with acute venous thrombophlebitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thrombophlebitis

Drugs mentioned

• Phlogenzym

Snippet

Sponsor: Mucos Pharma GmbH & Co. KG | Conditions: Thrombophlebitis Leg | Phase 3 | Status: COMPLETED